Human IGG B12 anti- primary HIV-1 isolates (PDB: 1HZH)
Welcome To The Antibody Society Webpage
The Antibody Society was formed in 2007 to further the broad interests of antibody engineering and antibody therapeutics, as well as to safeguard the public interest by increasing discussion and activities to create the safe, thorough testing of antibody therapeutics. The Society encompasses this increasingly diverse field, by supporting the superstructure for the engineering of recombinant antibodies, single scaffold binders, etc. through basic and applied research by those in academics and the private sector. The Society also seeks to provide a forum and voice for the thousands of people now working on all facets of this global field. Read our Mission Statement.
The Antibody Society membership.The Antibody Society website is the vehicle for registration of new members, which is now possible via a secure online server,register here !
News and views
2012 San Diego - Annual Antibody Engineering and Antibody Therapeutics Meeting ! IBC’s 23rd Annual Antibody Engineering and 10th Annual Antibody Therapeutics International Conferences: December 2-6, 2012, San Diego, CA USA.
Listing of approved monoclonal antibodies ! A list has been composed of all therapeutic monoclonal antibodies approved or in review in the European Union or United States. The information is current as of February 1, 2012. Find the table here !
2011 San Diego - Annual Antibody Engineering and Antibody Therapeutics Meeting Report published !
IBC’s 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and 2011 Annual Meeting of The Antibody Society December 5-8, 2011, San Diego, CA USA
By: Johan Nilvebrant, D. Cameron Dunlop, Aroop Sircar, Thierry Wurch, Emilia Falkowska, Janice M. Reichert, Gustavo Helguera, Emily C. Piccione, Simon Brack and Sven BergerFind all info here !
Data Standards, an exciting new development! 'The Guidelines for Information About Therapy Experiments (GIATE)' are now available in a Tree format. Find all info here !
Protein Engineering Design & Selection (PEDS) is the Official Journal of The Antibody Society. Each year we devote one issue to our field, which is in October for 2012. View PEDS online
Submissions are due as soon as possible, but no later than the end of June. Please identify these submissions to PEDS as being for the Antibody Special Issue (PEDS-ASI) and they will receive an expedited review. If you want to reserve a space in advance please contact the PEDS-ASI team at the Society.
Use your personal or institutional subscriptions for access to PEDS. After one
year all papers published in PEDS are Open Access. Thus the previous Antibody
Special Issues may be read in their entirety: Sept 2011, April 2010 & March 2009.
Broad coverage of all topics relevant
to antibody research and development
mAbs is the therapeutics journal of The Antibody Society !
